Cynthia Sawhney Santillan MD, Presenter: Consultant, Robarts Clinical Trials Research Group

Claude B. Sirlin MD, Abstract Co-Author: Research Grant, General Electric Company Speakers Bureau, Bayer AG Consultant, Bayer AG

The purpose of this exhibit is 1. To review LI-RADS v2014 with an emphasis on changes from the previous version. 2. To discuss the changes in LI-RADS v2014 that bring it closer in alignment with criteria for HCC used by OPTN and AASLD. 3. To demonstrate the use of LI-RADS v2014 using sample CT and MR cases in a quiz format.

Background and Significance: Importance of accurate HCC staging Discussion of differences in target population and purpose for other systems for diagnosis of HCC, including AASLD and OPTN. LI-RADSv2014 Highlight changes in the diagnostic algorithm Review new content on hepatobiliary contrast agents and their role in LI-RADS Discuss changes in ancillary features that favor malignancy Quiz Radiologists will be presented with cases and asked to categorize them using LI-RADS. There will be an emphasis on cases that use information that is new or changed in LI-RADS v2014.

http://abstract.rsna.org/uploads/2014/14008236/14008236_llsw.pdf

Santillan, C, Sirlin, C, Updates to the Liver Imaging Reporting and Data System (LI-RADS) v2014: The Latest and Greatest.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14008236.html